C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2004
11/18/2004	WO2004099251A2 Compositions and methods for treatment of cryptococcosis
11/18/2004	WO2004099241A1 Hepatitis c virus ns5b polymerase inhibitor binding pocket
11/18/2004	WO2004098670A1 Method of regenerating tooth germ
11/18/2004	WO2004098621A1 Isolated/cloned human nt2 cell lines expressing serotonin and gaba
11/18/2004	WO2004098533A2 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
11/18/2004	WO2004098531A2 Increased transduction using abc transporter substrates and/or inhibitors
11/18/2004	WO2004098499A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/18/2004	WO2004098492A2 Trans-golgi network-associated processes, methods and compositions related thereto
11/18/2004	WO2004098490A2 Mesoderm and definitive endoderm cell populations
11/18/2004	WO2004098377A2 Methods and compositions for diagnosis and therapy of parkin-associated disorders
11/18/2004	WO2004098285A2 Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
11/18/2004	WO2004098271A1 Development of cytoplasmic male sterile brassica oleracea plants and the method of producing such plants
11/18/2004	WO2004089980A3 Therapeutic cancer vaccine
11/18/2004	WO2004067732A3 Polymer carriers with bonded saccharides for immobilization of biological systems
11/18/2004	WO2004067697B1 Icos+ suppresser t cells
11/18/2004	WO2004065616A3 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
11/18/2004	WO2004052079A3 Method for programmed differentiation of stem cells
11/18/2004	WO2004046337A3 Multilayered microcultures
11/18/2004	WO2004019893A3 Modulators of angiogenesis
11/18/2004	WO2004004447A3 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism
11/18/2004	WO2003102156A3 Heterologous stimulus-gated ion channels and methods of using same
11/18/2004	WO2003093443A3 Alcam and alcam modulators
11/18/2004	WO2003084312A3 Identification and characterization of an anthocyanin mutant (ant1) in tomato
11/18/2004	WO2003080805A3 Kinases and phosphatases
11/18/2004	WO2003073067A3 Rna detection enzymes
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	US20040231009 Using variation in sensory organ developmental genes to diagnose and treat nervous system disorders; tissue engineering and gene therapy
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040230034 Hybrid heterodimeric protein hormone and method of using same
11/18/2004	US20040230032 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/18/2004	US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
11/18/2004	US20040229788 Cell surface molecule mediating cell adhesion and signal transmission
11/18/2004	US20040229782 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/18/2004	US20040229363 Using osilating wave electroporation to increase membrane premeability and transfer heterologous nucleotide sequences and vectors into competent cells; bioreactors for generating exogenous proteins
11/18/2004	US20040229362 Method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding genetic tools, as well as the applications of these non-pathogenic amplicon vectors
11/18/2004	US20040229361 Mammalian cell line for use as tool in preparation of gene transfer sequences; tissue engineering; bioreactor for production of therapeutic proteins
11/18/2004	US20040229360 Transgenic ventricle tissue for use as tools in screening modulators and treatments for cardiovascular disorders; tissue targeted therapy
11/18/2004	US20040229357 Gibberellin 2-oxidase
11/18/2004	US20040229356 culturing light-density cells in a stem cell factor, erythropoietin, interleukin-3, dexamethasone and estradiol medium and re-culturing in a erythropoietin and insulin medium; cell differentiation
11/18/2004	US20040229355 Culture medium for long-term culture of hepatocytes
11/18/2004	US20040229354 Enhancement of humoral immune responses using a novel myeloid accessory cell
11/18/2004	US20040229353 Genetic engineering; incubation osteogenic cells with animal growth regulator; culturing; screening for bone cell spheroids
11/18/2004	US20040229352 Stimulating aveolar cell proliferation in respiratory tissues via aveolar progenitor cell transplantation; tissue-targeted therapy and engineering
11/18/2004	US20040229351 Adult multipotent human progenitor tissues for use in xenogenic tissue transplantation; tissue engineering; immunotherapy
11/18/2004	US20040229350 Producing human pluripotent progenitor cell line comprising; preparing progenitor cell mass, positioning mass onto feeder cell layer, culturing multilayers of cells, inoculate fresh nutrient broth and proliferate cells
11/18/2004	US20040229333 Electroprocessed fibrin-based matrices and tissues
11/18/2004	US20040229308 Kinesin polypeptide for use in identifying modulators for detection, treatment or prevention of cancer, nervous system and vesicular transport disorders
11/18/2004	US20040229274 Synaptic activation protein compositions and method
11/18/2004	US20040229273 Comprises nucleotide sequences coding flea molting regulatory protein for use in identifying modulators which prevent flea infestation; biological pest control; veterinary medicine
11/18/2004	US20040229266 RNA interference mediating small RNA molecules
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040229258 Methods of detecting neurological disorders
11/18/2004	US20040229239 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants
11/18/2004	US20040229238 Comprises kinesin polypeptides for use as tools in identifying modulators for the treatment and prevention of cancer, neurological and vesicular transport disorders
11/18/2004	US20040229232 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229209 Model for Alzheimer's disease and other neurodegenerative diseases
11/18/2004	US20040229205 Compositions for the storage of platelets
11/18/2004	US20040228870 Methods for promoting growth of bone, ligament, and cartilage
11/18/2004	US20040228859 inhibit binding of IGF-1 and IGF-II to IGF-IR so they act as antitumor by reducing tumor growth and/or prolonging the time of tumor progression; hybridoma cell lines; methods of preparing the compositions
11/18/2004	US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease
11/18/2004	US20040228848 activated allogeneic T-cells infused into immunocompetent cancer patients to elicit anti-tumor immune mechanism called the "Mirror Effect"; used to stimulate host immunity in a complete HLA mis-matched setting in patients that have not had a prior bone marrow transplant or received chemotherapy
11/18/2004	US20040228847 Progenitor cells and methods of using same
11/18/2004	US20040228846 Methods and reagents for treating glucose metabolic disorders
11/18/2004	US20040228845 Methods of using CD8+/TCR- facilitating cells (FC) for the engraftment of purified hematopoietic stem cells (HSC)
11/18/2004	US20040228843 Preparing chimeric expression vector for use as gene transfer tool in heterologous gene expression; tissue engineering
11/18/2004	US20040228840 Vector for integration of heterologous sequences into poxviral genomes
11/18/2004	US20040228835 Compositions and methods for modulating vascularization
11/18/2004	US20040228834 Compositions and methods for modulating vascularization
11/18/2004	DE10317400A1 EX-VIVO-Hautorganmodell aus Schweinehaut EX VIVO skin organ model from pig skin
11/18/2004	DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions
11/18/2004	CA2788000A1 Apparatus for harvesting a dermal micro-organ
11/18/2004	CA2748670A1 Dermal micro organs, methods and apparatuses for producing and using the same
11/18/2004	CA2748661A1 Dermal micro organs, methods and apparatuses for producing and using the same
11/18/2004	CA2748659A1 Dermal micro organs, methods and apparatuses for producing and using the same
11/18/2004	CA2684022A1 Mesoderm and definitive endoderm cell populations
11/18/2004	CA2524956A1 Method, apparatus and system for separating eucaryotic or procaryotic cells or other biological material from a suspension
11/18/2004	CA2524929A1 Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
11/18/2004	CA2524611A1 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system
11/18/2004	CA2524293A1 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
11/18/2004	CA2524277A1 Arg-pro-pro-gly-phe analogs as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/18/2004	CA2524063A1 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/18/2004	CA2523706A1 Dermal micro organs, methods and apparatuses for producing and using the same
11/18/2004	CA2523417A1 Method for storing tumor cells
11/18/2004	CA2522574A1 Hepatitis c virus ns5b polymerase inhibitor binding pocket
11/18/2004	CA2520891A1 Cultures of e1-immortalized cells and processes for culturing the same to increase product yields therefrom
11/18/2004	CA2487058A1 Mesoderm and definitive endoderm cell populations
11/17/2004	WO2004107200A1 System and method for controlling user interface properties with data
11/17/2004	EP1477808A1 Method for cell selection
11/17/2004	EP1477806A1 Method of determining ligand
11/17/2004	EP1477805A1 Method for cell selection
11/17/2004	EP1477557A1 transgenic plant resistant to mycotoxins and methods
11/17/2004	EP1477556A1 Method for the selection of cardiomyogenic cells or cardiomyocytes from mixed cell populations
11/17/2004	EP1477497A1 Humanized immunoglobulins and their production and use
11/17/2004	EP1477494A1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004	EP1476581A2 Recombinant bovine immunodeficiency virus based gene transfer system
11/17/2004	EP1476580A2 Multiple virus replicon culture systems
11/17/2004	EP1476578A2 Mismatch repair detection

1 ... 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 ... 1827